Nexgel, Inc. insider trading
Every open-market purchase and sale by Nexgel, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $0 0 trades by 0 insiders Insider sales, 5 years $95,453 17 trades by 2 insiders
3 months later: median −41.8% (−44.2% vs S&P 500)
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Nexgel, Inc.’s insiders pay?
From January 3, 2022 to December 29, 2025, 7 insiders reported 23 open-market purchases and 1 sale not made under a pre-set plan in Nexgel, Inc.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Glassman Steven Mark | Director | 5 | — | — | 0 | — | November 22, 2024 |
| Drapczuk Adam E III | Chief Financial Officer | 4 | — | — | 0 | — | November 22, 2024 |
| Henry Scott Robert | Director | 4 | — | — | 0 | — | August 27, 2024 |
| Zeldis Jerome B | Director | 4 | — | — | 0 | — | August 27, 2024 |
| Stefansky David | Director | 3 | — | — | 0 | — | June 1, 2023 |
| Stein John Nachum | Director | 3 | — | — | 0 | — | August 28, 2024 |
| Levy Adam R. | Chief Executive Officer | 0 | — | — | 1 | — | December 29, 2025 |